NanJing Pharmaceutical Co Ltd
SSE:600713
NanJing Pharmaceutical Co Ltd
Cash from Operating Activities
NanJing Pharmaceutical Co Ltd
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
NanJing Pharmaceutical Co Ltd
SSE:600713
|
Cash from Operating Activities
-¥2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-24%
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Cash from Operating Activities
¥11.9B
|
CAGR 3-Years
38%
|
CAGR 5-Years
33%
|
CAGR 10-Years
11%
|
|
S
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Cash from Operating Activities
¥5.2B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
11%
|
CAGR 10-Years
18%
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Cash from Operating Activities
¥6.3B
|
CAGR 3-Years
15%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Cash from Operating Activities
¥2.7B
|
CAGR 3-Years
28%
|
CAGR 5-Years
23%
|
CAGR 10-Years
31%
|
Huadong Medicine Co Ltd
SZSE:000963
|
Cash from Operating Activities
¥3.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
See Also
What is NanJing Pharmaceutical Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
-2B
CNY
Based on the financial report for Sep 30, 2023, NanJing Pharmaceutical Co Ltd's Cash from Operating Activities amounts to -2B CNY.
What is NanJing Pharmaceutical Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
-24%
Over the last year, the Cash from Operating Activities growth was -298%.